Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AMGEN INCAMGN · Entity 2832 | EVP & CFO | September 01, 2026 | September 04, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AMGEN INC
Report date September 01, 2026 · Filed September 04, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 16,860 |
Reported balance
Holding disclosure · report date 2026-09-01 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 16,860 F1: These Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan (the Equity Incentive Plan) and vest in four equal annual installments of 25% each, commencing on 8/7/2027. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. |
| Nqso (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $410.95 · Expires 2036-08-07 | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2026-09-01 · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · Balance Not disclosed F2: These non-qualified stock options were granted pursuant to the Equity Incentive Plan and vest and are exercisable in four equal annual installments of 25% each, commencing on 8/7/2027. |
Filing footnotes · ownership attribution and instrument terms
F1: These Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan (the Equity Incentive Plan) and vest in four equal annual installments of 25% each, commencing on 8/7/2027. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.
F2: These non-qualified stock options were granted pursuant to the Equity Incentive Plan and vest and are exercisable in four equal annual installments of 25% each, commencing on 8/7/2027.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 21, 2014 Filed May 22, 2014 21:15 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionNqso (Right to Buy) · Derivative | 2,150 | $0.00 Strike: $58.43 | $0.00 |
DisclosureSEC source: 0001127602-14-018510 · form4.xml · derivative · entry 5 Dittrich Thomas J.W. · CIK 0001491654 · VP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,150 shares Expires 2020-04-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 21, 2014 Filed May 22, 2014 21:15 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionNqso (Right to Buy) · Derivative | 1,980 | $0.00 Strike: $54.69 | $0.00 |
DisclosureSEC source: 0001127602-14-018510 · form4.xml · derivative · entry 4 Dittrich Thomas J.W. · CIK 0001491654 · VP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,040 Underlying: Common Stock · 1,980 shares Expires 2021-04-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 21, 2014 Filed May 22, 2014 21:15 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 4,130 | $112.83 | $465,983.77 |
DisclosureSEC source: 0001127602-14-018510 · form4.xml · nonDerivative · entry 3 Dittrich Thomas J.W. · CIK 0001491654 · VP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,589 F1 · price: The price reported is an average price. The prices ranged from $112.82 to $112.86 per share. Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC, the issuer or a security holder of the issuer. F2 · balance_after: The shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 583 RSUs which vest in one installment of 583 on 4/25/2015; 938 RSUs which vest in two installments of 462 on 4/27/2015 and 476 on 4/27/2016; 942 RSUs which vest in annual installments of 310, 311 and 321 on 4/26/2015, 4/26/2016 and 4/26/2017, respectively; and 681 RSUs which vest in annual installments of 224, 225 and 232 on 4/25/2015, 4/25/2017 and 4/25/2018, respectively. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F3 · balance_after: These shares include 40 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Read SEC document |
| May 21, 2014 Filed May 22, 2014 21:15 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 2,150 | $58.43 | $125,624.50 |
DisclosureSEC source: 0001127602-14-018510 · form4.xml · nonDerivative · entry 2 Dittrich Thomas J.W. · CIK 0001491654 · VP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,719 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 21, 2014 Filed May 22, 2014 21:15 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 1,980 | $54.69 | $108,286.20 |
DisclosureSEC source: 0001127602-14-018510 · form4.xml · nonDerivative · entry 1 Dittrich Thomas J.W. · CIK 0001491654 · VP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,569 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 27, 2014 Filed Apr 29, 2014 21:38 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 10 | $111.41 | $1,114.10 |
DisclosureSEC source: 0001127602-14-015506 · form4.xml · nonDerivative · entry 5 Dittrich Thomas J.W. · CIK 0001491654 · VP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,589 F2 · balance_after: The shares include the following RSUs granted under the Company's equity plans: 583 RSUs which vest in one installment of 583 on 4/25/2015; 938 RSUs which vest in two installments of 462 on 4/27/2015 and 476 on 4/27/2016; 942 RSUs which vest in annual installments of 310, 311 and 321 on 4/26/2015, 4/26/2016 and 4/26/2017, respectively; and 681 RSUs which vest in annual installments of 224, 225 and 232 on 4/25/2015, 4/25/2017 and 4/25/2018, respectively. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F3 · balance_after: These shares include 40 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Read SEC document |
| April 27, 2014 Filed Apr 29, 2014 21:38 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 255 | $111.41 | $28,409.55 |
DisclosureSEC source: 0001127602-14-015506 · form4.xml · nonDerivative · entry 4 Dittrich Thomas J.W. · CIK 0001491654 · VP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,599 Read SEC document |
| April 26, 2014 Filed Apr 29, 2014 21:38 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 170 | $111.41 | $18,939.70 |
DisclosureSEC source: 0001127602-14-015506 · form4.xml · nonDerivative · entry 3 Dittrich Thomas J.W. · CIK 0001491654 · VP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,854 Read SEC document |
| April 25, 2014 Filed Apr 29, 2014 21:38 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 681 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-14-015506 · form4.xml · nonDerivative · entry 2 Dittrich Thomas J.W. · CIK 0001491654 · VP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,024 F1 · shares: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vest in three annual installments of 33%, 33% and 34% on 4/25/2016, 4/25/2017 and 4/25/2018, respectively. Read SEC document |
| April 25, 2014 Filed Apr 29, 2014 21:38 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 312 | $113.72 | $35,480.64 |
DisclosureSEC source: 0001127602-14-015506 · form4.xml · nonDerivative · entry 1 Dittrich Thomas J.W. · CIK 0001491654 · VP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,343 Read SEC document |
| March 14, 2014 Filed Mar 18, 2014 20:24 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 2,316 | $123.96 | $287,091.36 |
DisclosureSEC source: 0001127602-14-012013 · form4.xml · nonDerivative · entry 1 Dittrich Thomas J.W. · CIK 0001491654 · VP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,655 F1 · balance_after: The shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 308 RSUs which fully vest on 4/26/2014; 1,149 RSUs which vest in annual installments of 566 and 583 on 4/25/2014 and 4/25/2015, respectively; 1,400 RSUs which vest in two equal installments of 462 each on 4/27/2014 and 4/27/2015 and one installment of 476 on 4/27/2016; and 942 RSUs which vest in annual installments of 310, 311 and 321 on 4/26/2015, 4/26/2016 and 4/26/2017, respectively. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F2 · balance_after: These shares include 57 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan, as amended and restated, and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Read SEC document |
| March 05, 2014 Filed Mar 7, 2014 22:33 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 4,207 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-14-010754 · form4.xml · nonDerivative · entry 1 Dittrich Thomas J.W. · CIK 0001491654 · VP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,971 F1 · balance_after: The shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 308 RSUs which fully vest on 4/26/2014; 1,149 RSUs which vest in annual installments of 566 and 583 on 4/25/2014 and 4/25/2015, respectively; 1,400 RSUs which vest in two equal installments of 462 each on 4/27/2014 and 4/27/2015 and one installment of 476 on 4/27/2016; and 942 RSUs which vest in annual installments of 310, 311 and 321 on 4/26/2015, 4/26/2016 and 4/26/2017, respectively. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F2 · balance_after: These shares include 26 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan, as amended and restated, and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Read SEC document |
| May 22, 2013 Filed May 24, 2013 21:18 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionNqso (Right to Buy) · Derivative | 1,980 | $0.00 Strike: $54.69 | $0.00 |
DisclosureSEC source: 0001127602-13-018291 · form4.xml · derivative · entry 7 Dittrich Thomas J.W. · CIK 0001491654 · VP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,020 Underlying: Common Stock · 1,980 shares Expires 2021-04-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 22, 2013 Filed May 24, 2013 21:18 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionNqso (Right to Buy) · Derivative | 2,150 | $0.00 Strike: $58.43 | $0.00 |
DisclosureSEC source: 0001127602-13-018291 · form4.xml · derivative · entry 6 Dittrich Thomas J.W. · CIK 0001491654 · VP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,150 Underlying: Common Stock · 2,150 shares Expires 2020-04-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 22, 2013 Filed May 24, 2013 21:18 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionNqso (Right to Buy) · Derivative | 2,000 | $0.00 Strike: $50.44 | $0.00 |
DisclosureSEC source: 0001127602-13-018291 · form4.xml · derivative · entry 5 Dittrich Thomas J.W. · CIK 0001491654 · VP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,000 shares Expires 2016-04-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 22, 2013 Filed May 24, 2013 21:18 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 6,130 | $104.78 | $642,296.50 |
DisclosureSEC source: 0001127602-13-018291 · form4.xml · nonDerivative · entry 4 Dittrich Thomas J.W. · CIK 0001491654 · VP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,733 F1 · price: The price reported is an average price. The prices ranged from $104.7601 to $104.83 per share. Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC, the issuer or a security holder of the issuer. F2 · balance_after: The shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 308 RSUs which fully vest on 4/26/2014; 1,149 RSUs which vest in annual installments of 566 and 583 on 4/25/2014 and 4/25/2015, respectively; 1,400 RSUs which vest in two equal installments of 462 each on 4/27/2014 and 4/27/2015 and one installment of 476 on 4/27/2016; and 942 RSUs which vest in annual installments of 310, 311 and 321 on 4/26/2015, 4/26/2016 and 4/26/2017, respectively. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F3 · balance_after: These shares include 26 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan, as amended and restated, and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Read SEC document |
| May 22, 2013 Filed May 24, 2013 21:18 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 1,980 | $54.69 | $108,286.20 |
DisclosureSEC source: 0001127602-13-018291 · form4.xml · nonDerivative · entry 3 Dittrich Thomas J.W. · CIK 0001491654 · VP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,863 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 22, 2013 Filed May 24, 2013 21:18 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 2,150 | $58.43 | $125,624.50 |
DisclosureSEC source: 0001127602-13-018291 · form4.xml · nonDerivative · entry 2 Dittrich Thomas J.W. · CIK 0001491654 · VP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,883 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 22, 2013 Filed May 24, 2013 21:18 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 2,000 | $50.44 | $100,880.00 |
DisclosureSEC source: 0001127602-13-018291 · form4.xml · nonDerivative · entry 1 Dittrich Thomas J.W. · CIK 0001491654 · VP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,733 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 28, 2013 Filed Apr 30, 2013 21:14 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 91 | $108.38 | $9,862.58 |
DisclosureSEC source: 0001127602-13-014769 · form4.xml · nonDerivative · entry 3 Dittrich Thomas J.W. · CIK 0001491654 · VP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,733 F2 · balance_after: The shares include the following RSUs granted under the Company's equity plans: 308 RSUs which fully vest on 4/26/2014; 1,149 RSUs which vest in annual installments of 566 and 583 on 4/25/2014 and 4/25/2015, respectively; 1,400 RSUs which vest in two equal installments of 462 each on 4/27/2014 and 4/27/2015 and one installment of 476 on 4/27/2016; and 942 RSUs which vest in annual installments of 310, 311 and 321 on 4/26/2015, 4/26/2016 and 4/26/2017, respectively. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F3 · balance_after: These shares include 26 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Read SEC document |
| April 26, 2013 Filed Apr 30, 2013 21:14 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 98 | $108.66 | $10,648.68 |
DisclosureSEC source: 0001127602-13-014769 · form4.xml · nonDerivative · entry 2 Dittrich Thomas J.W. · CIK 0001491654 · VP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,824 Read SEC document |
| April 26, 2013 Filed Apr 30, 2013 21:14 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 942 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-13-014769 · form4.xml · nonDerivative · entry 1 Dittrich Thomas J.W. · CIK 0001491654 · VP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,922 F1 · shares: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and vest in three annual installments of 33%, 33% and 34% on 4/26/2015, 4/26/2016 and 4/26/2017, respectively. Read SEC document |
| April 25, 2013 Filed Apr 29, 2013 22:00 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 179 | $104.93 | $18,782.47 |
DisclosureSEC source: 0001127602-13-014705 · form4.xml · nonDerivative · entry 1 Dittrich Thomas J.W. · CIK 0001491654 · VP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,980 F1 · balance_after: The shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 286 RSUs which fully vest on 4/28/2013; 615 RSUs which vest in annual installments of 307 on 4/26/2013 and 308 on 4/26/2014; 1,149 RSUs which vest in annual installments of 566 and 583 on 4/25/2014 and 4/25/2015, respectively; and 1,400 RSUs which vest in two equal installments of 462 each on 4/27/2014 and 4/27/2015 and one installment of 476 on 4/27/2016. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F2 · balance_after: These shares include 26 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Read SEC document |
| March 15, 2013 Filed Mar 19, 2013 23:41 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 1,121 | $92.18 | $103,333.78 |
DisclosureSEC source: 0001127602-13-011472 · form4.xml · nonDerivative · entry 1 Dittrich Thomas J.W. · CIK 0001491654 · VP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,159 F1 · balance_after: The shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 286 RSUs which fully vest on 4/28/2013; 615 RSUs which vest in annual installments of 307 on 4/26/2013 and 308 on 4/26/2014; 1,714 RSUs which vest in annual installments of 565, 566 and 583 on 4/25/2013, 4/25/2014 and 4/25/2015, respectively; and 1,400 RSUs which vest in two equal installments of 462 each on 4/27/2014 and 4/27/2015 and one installment of 476 on 4/27/2016. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F2 · balance_after: These shares include 26 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Read SEC document |
| March 06, 2013 Filed Mar 8, 2013 23:15 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 3,540 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-13-010156 · form4.xml · nonDerivative · entry 1 Dittrich Thomas J.W. · CIK 0001491654 · VP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,273 F1 · balance_after: The shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 286 RSUs which fully vest on 4/28/2013; 615 RSUs which vest in annual installments of 307 on 4/26/2013 and 308 on 4/26/2014; 1,714 RSUs which vest in annual installments of 565, 566 and 583 on 4/25/2013, 4/25/2014 and 4/25/2015, respectively; and 1,400 RSUs which vest in two equal installments of 462 each on 4/27/2014 and 4/27/2015 and one installment of 476 on 4/27/2016. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F2 · balance_after: These shares include 19 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Read SEC document |
| July 31, 2012 Filed Aug 1, 2012 23:39 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionNqso (Right to Buy) · Derivative | 2,150 | $0.00 Strike: $58.43 | $0.00 |
DisclosureSEC source: 0001127602-12-023455 · form4.xml · derivative · entry 9 Dittrich Thomas J.W. · CIK 0001491654 · VP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,300 Underlying: Common Stock · 2,150 shares Expires 2020-04-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 31, 2012 Filed Aug 1, 2012 23:39 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionNqso (Right to Buy) · Derivative | 2,000 | $0.00 Strike: $50.44 | $0.00 |
DisclosureSEC source: 0001127602-12-023455 · form4.xml · derivative · entry 8 Dittrich Thomas J.W. · CIK 0001491654 · VP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 Underlying: Common Stock · 2,000 shares Expires 2016-04-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 31, 2012 Filed Aug 1, 2012 23:39 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionNqso (Right to Buy) · Derivative | 3,000 | $0.00 Strike: $42.13 | $0.00 |
DisclosureSEC source: 0001127602-12-023455 · form4.xml · derivative · entry 7 Dittrich Thomas J.W. · CIK 0001491654 · VP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,000 shares Expires 2015-04-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 31, 2012 Filed Aug 1, 2012 23:39 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionNqso (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $69.83 | $0.00 |
DisclosureSEC source: 0001127602-12-023455 · form4.xml · derivative · entry 6 Dittrich Thomas J.W. · CIK 0001491654 · VP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 25,000 shares Expires 2013-05-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 31, 2012 Filed Aug 1, 2012 23:39 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 32,150 | $82.69 | $2,658,387.05 |
DisclosureSEC source: 0001127602-12-023455 · form4.xml · nonDerivative · entry 5 Dittrich Thomas J.W. · CIK 0001491654 · VP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,721 F1 · price: The price reported is an average price. The prices ranged from $82.67 to $82.75 per share. Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC, the issuer or a security holder of the issuer. F2 · balance_after: The shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 286 RSUs which fully vest on 4/28/2013; 615 RSUs which vest in annual installments of 307 on 4/26/2013 and 308 on 4/26/2014; 1,714 RSUs which vest in annual installments of 565, 566 and 583 on 4/25/2013, 4/25/2014 and 4/25/2015, respectively; and 1,400 RSUs which vest in two equal installments of 462 each on 4/27/2014 and 4/27/2015 and one installment of 476 on 4/27/2016. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F3 · balance_after: These shares include 7 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Read SEC document |
| July 31, 2012 Filed Aug 1, 2012 23:39 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 2,150 | $58.43 | $125,624.50 |
DisclosureSEC source: 0001127602-12-023455 · form4.xml · nonDerivative · entry 4 Dittrich Thomas J.W. · CIK 0001491654 · VP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,871 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 31, 2012 Filed Aug 1, 2012 23:39 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 2,000 | $50.44 | $100,880.00 |
DisclosureSEC source: 0001127602-12-023455 · form4.xml · nonDerivative · entry 3 Dittrich Thomas J.W. · CIK 0001491654 · VP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,721 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 31, 2012 Filed Aug 1, 2012 23:39 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 3,000 | $42.13 | $126,390.00 |
DisclosureSEC source: 0001127602-12-023455 · form4.xml · nonDerivative · entry 2 Dittrich Thomas J.W. · CIK 0001491654 · VP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,721 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 31, 2012 Filed Aug 1, 2012 23:39 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 25,000 | $69.83 | $1,745,750.00 |
DisclosureSEC source: 0001127602-12-023455 · form4.xml · nonDerivative · entry 1 Dittrich Thomas J.W. · CIK 0001491654 · VP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,721 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 29, 2012 Filed May 2, 2012 00:45 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 233 | $71.64 | $16,692.12 |
DisclosureSEC source: 0001127602-12-015249 · form4.xml · nonDerivative · entry 3 Dittrich Thomas J.W. · CIK 0001491654 · VP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,714 F2 · balance_after: The shares include the following RSUs granted under the Company's equity plans: 286 RSUs which fully vest on 4/28/2013; 615 RSUs which vest in annual installments of 307 on 4/26/2013 and 308 on 4/26/2014; 1,714 RSUs which vest in annual installments of 565, 566 and 583 on 4/25/2013, 4/25/2014 and 4/25/2015, respectively; and 1,400 RSUs which vest in two equal installments of 462 each on 4/27/2014 and 4/27/2015 and one installment of 476 on 4/27/2016. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. Read SEC document |
| April 28, 2012 Filed May 2, 2012 00:45 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 78 | $71.64 | $5,587.92 |
DisclosureSEC source: 0001127602-12-015249 · form4.xml · nonDerivative · entry 2 Dittrich Thomas J.W. · CIK 0001491654 · VP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,947 Read SEC document |
| April 27, 2012 Filed May 2, 2012 00:45 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 1,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-12-015249 · form4.xml · nonDerivative · entry 1 Dittrich Thomas J.W. · CIK 0001491654 · VP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,025 F1 · shares: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and vest in three annual installments of 33%, 33% and 34% on 4/27/2014, 4/27/2015 and 4/27/2016, respectively. Read SEC document |
| April 26, 2012 Filed Apr 30, 2012 22:03 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 84 | $70.19 | $5,895.96 |
DisclosureSEC source: 0001127602-12-014979 · form4.xml · nonDerivative · entry 1 Dittrich Thomas J.W. · CIK 0001491654 · VP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,625 F1 · balance_after: The shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 857 RSUs which fully vest on 4/29/2012; 572 RSUs which vest in two equal annual installments of 286 each commencing 4/28/2012; 615 RSUs which vest in annual installments of 307 on 4/26/2013 and 308 on 4/26/2014; and 1,714 RSUs which vest in annual installments of 565, 566 and 583 on 4/25/2013, 4/25/2014 and 4/25/2015, respectively. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. Read SEC document |
| March 16, 2012 Filed Mar 20, 2012 21:48 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 283 | $68.26 | $19,317.58 |
DisclosureSEC source: 0001127602-12-011445 · form4.xml · nonDerivative · entry 1 Dittrich Thomas J.W. · CIK 0001491654 · VP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,709 F1 · balance_after: The shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 857 RSUs which fully vest on 4/29/2012; 572 RSUs which vest in two equal annual installments of 286 each commencing 4/28/2012; 922 RSUs which vest in two equal installments of 307 each on 4/26/2012 and 4/26/2013 and one installment of 308 on 4/26/2014; and 1,714 RSUs which vest in annual installments of 565, 566 and 583 on 4/25/2013, 4/25/2014 and 4/25/2015, respectively. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. Read SEC document |
| March 14, 2012 Filed Mar 15, 2012 23:50 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 1,040 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-12-010813 · form4.xml · nonDerivative · entry 1 Dittrich Thomas J.W. · CIK 0001491654 · VP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,992 F1 · balance_after: The shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 857 RSUs which fully vest on 4/29/2012; 572 RSUs which vest in two equal annual installments of 286 each commencing 4/28/2012; 922 RSUs which vest in two equal installments of 307 each on 4/26/2012 and 4/26/2013 and one installment of 308 on 4/26/2014; and 1,714 RSUs which vest in annual installments of 565, 566 and 583 on 4/25/2013, 4/25/2014 and 4/25/2015, respectively. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. Read SEC document |
| January 30, 2012 Filed Feb 1, 2012 23:41 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionNqso (Right to Buy) · Derivative | 2,150 | $0.00 Strike: $58.43 | $0.00 |
DisclosureSEC source: 0001127602-12-003435 · form4.xml · derivative · entry 9 Dittrich Thomas J.W. · CIK 0001491654 · VP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,450 Underlying: Common Stock · 2,150 shares Expires 2020-04-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 30, 2012 Filed Feb 1, 2012 23:41 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionNqso (Right to Buy) · Derivative | 4,000 | $0.00 Strike: $50.44 | $0.00 |
DisclosureSEC source: 0001127602-12-003435 · form4.xml · derivative · entry 8 Dittrich Thomas J.W. · CIK 0001491654 · VP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,000 Underlying: Common Stock · 4,000 shares Expires 2016-04-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 30, 2012 Filed Feb 1, 2012 23:41 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionNqso (Right to Buy) · Derivative | 9,000 | $0.00 Strike: $42.13 | $0.00 |
DisclosureSEC source: 0001127602-12-003435 · form4.xml · derivative · entry 7 Dittrich Thomas J.W. · CIK 0001491654 · VP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,000 Underlying: Common Stock · 9,000 shares Expires 2015-04-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 30, 2012 Filed Feb 1, 2012 23:41 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionNqso (Right to Buy) · Derivative | 11,000 | $0.00 Strike: $62.55 | $0.00 |
DisclosureSEC source: 0001127602-12-003435 · form4.xml · derivative · entry 6 Dittrich Thomas J.W. · CIK 0001491654 · VP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,000 shares Expires 2014-04-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 30, 2012 Filed Feb 1, 2012 23:41 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 26,150 | $68.26 | $1,784,931.01 |
DisclosureSEC source: 0001127602-12-003435 · form4.xml · nonDerivative · entry 5 Dittrich Thomas J.W. · CIK 0001491654 · VP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,952 F1 · price: The price reported is an average price. The prices ranged from $68.21 to $68.29 per share. Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC staff, the issuer or a security holder of the issuer. F2 · balance_after: The shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 857 RSUs which fully vest on 4/29/2012; 572 RSUs which vest in two equal annual installments of 286 each commencing 4/28/2012; 922 RSUs which vest in two equal installments of 307 each on 4/26/2012 and 4/26/2013 and one installment of 308 on 4/26/2014; and 1,714 RSUs which vest in annual installments of 565, 566 and 583 on 4/25/2013, 4/25/2014 and 4/25/2015, respectively. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. Read SEC document |
| January 30, 2012 Filed Feb 1, 2012 23:41 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 2,150 | $58.43 | $125,624.50 |
DisclosureSEC source: 0001127602-12-003435 · form4.xml · nonDerivative · entry 4 Dittrich Thomas J.W. · CIK 0001491654 · VP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,102 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 30, 2012 Filed Feb 1, 2012 23:41 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 4,000 | $50.44 | $201,760.00 |
DisclosureSEC source: 0001127602-12-003435 · form4.xml · nonDerivative · entry 3 Dittrich Thomas J.W. · CIK 0001491654 · VP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,952 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 30, 2012 Filed Feb 1, 2012 23:41 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 9,000 | $42.13 | $379,170.00 |
DisclosureSEC source: 0001127602-12-003435 · form4.xml · nonDerivative · entry 2 Dittrich Thomas J.W. · CIK 0001491654 · VP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,952 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 30, 2012 Filed Feb 1, 2012 23:41 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 11,000 | $62.55 | $688,050.00 |
DisclosureSEC source: 0001127602-12-003435 · form4.xml · nonDerivative · entry 1 Dittrich Thomas J.W. · CIK 0001491654 · VP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,952 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 31, 2011 Filed Aug 3, 2011 00:59 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 679 | $54.70 | $37,141.30 |
DisclosureSEC source: 0001127602-11-022646 · form4.xml · nonDerivative · entry 1 Dittrich Thomas J.W. · CIK 0001491654 · VP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,952 F1 · balance_after: These shares include the corrected beneficial ownership total, as amended by the Form 3/A filed on August 2, 2011. The shares also include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 857 RSUs which fully vest on 4/29/2012; 572 RSUs which vest in two equal annual installments of 286 each commencing 4/28/2012; 922 RSUs which vest in two equal installments of 307 each on 4/26/2012 and 4/26/2013 and one installment of 308 on 4/26/2014; and 1,714 RSUs which vest in annual installments of 565, 566 and 583 on 4/25/2013, 4/25/2014 and 4/25/2015, respectively. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.